Clinical Trials

10 enrolled

Pancreatic Neoplasms

NCT06496373 2025-11-17

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

20 enrolled

Pancreatic Neoplasms

NCT07229768 2025-11-17

Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors

4 enrolled

Pancreatic Neoplasms

NCT05438667 2025-09-08

TCR-T Cell Therapy on Advanced Solid Tumors

18 enrolled

Phase EARLY_PHASE1 Active not recruiting

Pancreatic Neoplasms

NCT05141643 2025-09-04

Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer

30 enrolled

Phase EARLY_PHASE1 Active not recruiting

Pancreatic Neoplasms

NCT04147494 2025-08-12

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

29 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT07026981 2025-08-08

[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers

GastrointestinalHead & Neck

12 enrolled

Head and Neck Neoplasms, Pancreatic Neoplasms

NCT03572283 2025-06-05

Bethanechol Prior to Pancreatic Surgery

17 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT06122896 2025-06-03

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

5,000 enrolled

Pancreatic Neoplasms

NCT04665947 2025-05-28

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT06577532 2025-05-21

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

56 enrolled

Pancreatic Neoplasms

NCT00902759 2025-05-02

Fatigue and Pancreas and Bile Duct Cancer Study

100 enrolled

Fatigue, Pancreatic Neoplasms

NCT02896907 2025-04-30

Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

8 enrolled 9 charts

Pancreatic Neoplasms

NCT04048278 2025-03-03

Lidocaine Infusion in Pancreatic Cancer

46 enrolled

Pancreatic Neoplasms

NCT01821612 2025-01-13

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

23 enrolled

Pancreatic Neoplasms

NCT03153410 2025-01-09

Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas

11 enrolled 14 charts

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT06645301 2024-10-16

BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies

15 enrolled

Pancreatic Neoplasms, Colorectal Neoplasms

NCT06619886 2024-10-01

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

Phase EARLY_PHASE1 Active not recruiting

9 enrolled

GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05482451 2024-08-21

Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

CNSGastrointestinalGenitourinaryGynecologic

197 enrolled

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT03492164 2024-06-12

In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

Phase EARLY_PHASE1 Terminated

6 enrolled

Pancreatic Neoplasms

NCT06284226 2024-04-16

CCT-ANK-11

GastrointestinalGynecologicThoracic

Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

12 enrolled

Phase EARLY_PHASE1 Terminated

Pancreatic Neoplasms

NCT03519308 2024-03-15

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

3 enrolled 13 charts

Pancreatic Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT06196658 2024-01-09

Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer

6 enrolled

Pancreatic Neoplasms

NCT04870034 2023-12-22

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05465590 2023-12-21

A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06156267 2023-12-05

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

30 enrolled

Phase EARLY_PHASE1 Unknown

Pancreatic Neoplasms

NCT06054984 2023-10-13

GB3010-02

18 enrolled

Pancreatic Neoplasms

NCT02683824 2023-09-21

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

21 enrolled